Table 3.
Blood Contents Change. “*” indicates significant difference.
| Thrombolysis Treatments (N = 14) | Free-flow Treatments (N = 8) | Two Weeks of Recovery (N = 4) | ||||
|---|---|---|---|---|---|---|
| Baseline1 | Post | Baseline2 | Post | Baseline3 | Two weeks later | |
| Free Hgb (mg/dL) | 3.8 ± 3.4 | 63.2± 21.6* | 56.7 ± 25.1 | 78.1 ± 13.9 | 2.3 ± 0.8 | 2.1 ± 1.0 |
| LDH (U/L) | 404.4 ± 104.3 | 524.6 ± 130.1* | 554.1 ± 132.0 | 608.4 ± 164.5 | 355.0 ± 78.0 | 334.5 ± 67.0 |
| K (mmol/L) | 4.1 ± 0.2 | 4.9 ± 0.5* | 4.7 ± 0.4 | 4.9 ± 0.5 | 4.0 ± 0.3 | 3.6 ± 0.2 |
| Serum Hematocrit (%PCV) | 26.6 ± 2.5 | 27.1 ± 3.2 | 27.3 ± 3.9 | 27.3 ± 3.1 | 28.3 ± 1.0 | 25.3 ± 3.6 |
| pH | 7.3 ± 0.1 | 7.3 ± 0.1 | 7.4 ± 0.1 | 7.4 ± 0.1 | 7.3 ± 0.1 | 7.4 ± 0.03 |
| SBP (mmHg) | 81.4 ± 11.2 | 86.6 ± 10.8 | 84.5 ± 9.2 | 86.0 ± 11.3 | NA | NA |
| HR (BPM) | 79.8 ± 11.2 | 79.9 ± 12.5 | 76.6 ± 13.6 | 78.4 ± 14.5 | NA | NA |
1
The baselines are the measurements before any treatments and calculated using all 14 samples.
2
The baselines are the measurements after the thrombolysis treatments and before the free-flow treatments and calculated only using the corresponding 8 samples.
3
The baselines are the measurements before any treatments and calculated only using the corresponding 4 samples.